Skip to content
Research use only — not for human consumptionBatch documentation on requestThird-party tested purityDiscreet EU delivery21+ onlyMade in EuropeResearch use only — not for human consumptionBatch documentation on requestThird-party tested purityDiscreet EU delivery21+ onlyMade in Europe

RUO · 21+ Research Use Only (RUO). All products sold on this website are intended for research use only. They are not medicines, food supplements, or drugs for human or animal consumption, and are not intended to diagnose, treat, cure or prevent any disease or medical condition. By using this site you confirm you are 21+ and purchasing for legitimate laboratory research purposes only. Read full research use policy

norecipe
CJC-1295 No DAC (5mg) + Ipamorelin (10mg) | Peptide PenResearch use only

CJC-1295 No DAC (5mg) + Ipamorelin (10mg) | Peptide Pen

CJC-1295 (No DAC) is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH 1-29), designed to stimulate the pituitary’s natural growth hormone secretion through transient receptor activation. The “No DAC” means this version does not contain the Drug Affinity Complex modification.

Without DAC: CJC-1295 (No DAC), also known as Mod GRF 1-29, has a short half-life (≈30 minutes) and produces pulsatile, physiological GH release.

With DAC: The DAC modification forms a covalent bond to serum albumin, creating a long-acting analogue with a half-life of ≈6–8 days, used in research on sustained GH exposure.

210,00 €incl. VAT
In stockRUO
1

Discreet EU shipping. Certificate of analysis available on request. Not for human or animal consumption.

Storage
Store at 2–8 °C. Do not freeze. Shipped with ice packs.
Format
Pre-filled pen

CJC-1295 (No DAC) is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH 1-29), designed to stimulate the pituitary’s natural growth hormone secretion through transient receptor activation. The “No DAC” means this version does not contain the Drug Affinity Complex modification. Without DAC: CJC-1295 (No DAC), also known as Mod GRF 1-29, has a short half-life (≈30 minutes) and produces pulsatile, physiological GH release. With DAC: The DAC modification forms a covalent bond to serum albumin, creating a long-acting analogue with a half-life of ≈6–8 days, used in research on sustained GH exposure. Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist that acts synergistically with GHRH analogues. When combined, CJC-1295 (No DAC) and Ipamorelin are studied for their complementary stimulation of the GH axis through independent receptor pathways. Fields of Study Growth hormone secretion studies Metabolic and endocrine regulation Muscle growth and repair Energy and recovery research

Fields of study

  • Growth hormone secretion studies
  • Metabolic and endocrine regulation
  • Muscle growth and repair
  • Energy and recovery research

Related compounds

View all